Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma

Cited by (207)

Items 101–200 of 207

1. APOBEC affects tumor evolution and age at onset of lung cancer in smokers
   Tongwu Zhang, Jian Sang, Phuc H. Hoang, Zhao Wei, Jennifer Rosenbaum, Kofi Ennu Johnson, Leszek J. Klimczak, John P. McElderry, Alyssa Klein, Christopher Wirth et al. · 2025 · Nature Communications
2. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification
   Chen Gao, Ning Kong, Fan Zhang, Tianyu Tang, Jiaying Li, Honglei Ding, Zhichao Sun, Linyu Wu, Maosheng Xu · 2022 · BMC Medical Genomics
3. Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosis
   Chen Gao, Ning Kong, Fan Zhang, Liuzhi Zhou, Maosheng Xu, Linyu Wu · 2022 · BMC Bioinformatics
4. Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers
   Taek-Chin Cheong, Ahram Jang, Qi Wang, Giulia Costanza Leonardi, Biagio Ricciuti, Joao V. Alessi, Alessandro Di Federico, Mark Magdi Awad, Maria K. Lehtinen, Marian H. Harris et al. · 2024 · Nature Communications
5. Hi-C as a molecular rangefinder to examine genomic rearrangements
   Kyukwang Kim, Mooyoung Kim, Yubin Kim, Dong-Sung Lee, Inkyung Jung · 2021 · Seminars in Cell and Developmental Biology
6. Microbiota modulate lung squamous cell carcinoma lymph node metastasis through microbiota-geneset correlation network
   Peng Liang, Hongsheng Deng, Yi Zhao, Ying Chen, Jingna Zhang, Jianxing He, Wenhua Liang · 2023 · Translational Lung Cancer Research
7. Analysis of potential genetic biomarkers and molecular mechanism of smoking-related postmenopausal osteoporosis using weighted gene co-expression network analysis and machine learning
   Shaoshuo Li, Baixing Chen, Hao Chen, Zhen Hua, Yang Shao, Heng Yin, Jianwei Wang · 2021 · PLoS ONE
8. Analysis of CD74 Occurrence in Oncogenic Fusion Proteins
   2023
9. Modelling the ageing dependence of cancer evolutionary trajectories
   Curtis James Henry, James V. DeGregori · 2025 · Nature reviews. Cancer
10. Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model
    Milena Simovic-Lorenz, Michiel Bolkestein, Mahmoud Moustafa, John Wong, Verena Körber, Sarah Benedetto, Umar Khalid, Hannah Sophia Schreiber, Manfred Jugold, Andrey Korshunov et al. · 2021 · Neuro-Oncology
11. β-Hydroxybutyrate dehydrogenase 1: A promising therapeutic target for diverse diseases
    Xiaotong Ma, Ze Wang, Haoyang Gao, Danlin Zhu, Mingyu Wu, Linlin Zhao, Weihua Xiao · 2025 · Biochemical Pharmacology
12. Cancer evolution: from Darwin to the Extended Evolutionary Synthesis
    Thomas Savy, Lucy Flanders, Thaneswari Karpanasamy, Min Sun, Marco Gerlinger · 2025 · Trends in cancer
13. Multi-Omics Mining of lncRNAs with Biological and Clinical Relevance in Cancer
    Iván Salido-Guadarrama, Sandra Lorena Romero-Cordoba, Bertha Rueda-Zarazúa · 2023 · International Journal of Molecular Sciences
14. Distinct Patterns of Somatic Genomic Alterations and Mutational Signatures in Central and Peripheral-Type Small-Cell Lung Cancer
    Lei Wang, Jing Wang, Juanni Hu, Lele Song, Jian Ni, Yayi He, Caicun Zhou · 2020 · Translational Lung Cancer Research
15. Multiplatform discovery and regulatory function analysis of structural variations in non-small cell lung carcinoma
    Xia Lin, Zhoufeng Wang, Xinyue Wu, Tianfu Zeng, Wenxin Luo, Xinlei Hu, Yinyun Ni, Guowei Che, Lunxu Liu, Wei jin Zhang et al. · 2021 · Cell Reports
16. Knockdown of mitochondrial threonyl-tRNA synthetase 2 inhibits lung adenocarcinoma cell proliferation and induces apoptosis
    Hui Tian, Hao Yan, Yong Zhang, Qiaofen Fu, Chunyan Li, Juan He, Hui Li, Yong Chun Zhou, Youguang Huang, Rongqing Li · 2022 · Bioengineered
17. Association between the mutational smoking signature and the immune microenvironment in lung adenocarcinoma
    Kei A. Sato, Sachiyo Mimaki, Riu Yamashita, Yosuke Togashi, Tomoyuki Naito, Hibiki Udagawa, Shinya Katsumata, Shoko Nakasone, Tomohiro Miyoshi, Kenta Tane et al. · 2020 · Lung Cancer
18. Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma
    Xiuyu Cai, Zhenghe Chen, Meiling Deng, Zhiyong Li, Qianchao Wu, Jinwang Wei, Chun Dai, Guan Wang, Chun Luo · 2020 · Annals of Translational Medicine
19. Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma
    Lu Liang, Yueying Liu, Shiyao Jiang, Jingjing Huang, Hua He, Li Shen, Cong Li, Yiqun Jiang · 2022 · Journal of Immunology Research
20. Inflammation Promotes Aging‐Associated Oncogenesis in the Lung
    Catherine Pham‐Danis, Shi B. Chia, Hannah A. Scarborough, Etienne P. Danis, Travis G. Nemkov, Vadym Zaberezhnyy, Jessica L. Christenson, Emily K. Kleczko, Andre Navarro, Andrew E. Goodspeed et al. · 2024 · Aging and Cancer
21. A fusion of CD63–BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis
    Kieun Bae, Jin Hee Kim, Hyojik Jung, Sun‐Young Kong, Yun‐Hee Kim, Sunshin Kim, Geon Kook Lee, Jin Soo Lee, Jake June-Koo Lee, Young Seok Ju et al. · 2020 · British Journal of Cancer
22. Multi-Omics Integrative Bioinformatics Analyses Reveal Long Non-coding RNA Modulates Genomic Integrity via Competing Endogenous RNA Mechanism and Serves as Novel Biomarkers for Overall Survival in Lung Adenocarcinoma
    Zhonglin Wang, Ziyuan Ren, Rui Li, Junpeng Ge, Guo‐Ming Zhang, Yaodong Xin, Yi-Qing Qu · 2021 · Frontiers in Cell and Developmental Biology
23. Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage
    Xiaobing Wu, Maoni Guo, Jian Cui, Haoyang Cai, San Ming Wang · 2022 · Oncogenesis
24. Tectoridin and PLK1 inhibitor synergistically promote the apoptosis of lung adenocarcinoma cells: Bioinformatic analysis of TCGA and TCMSP
    Meng Wang, Fei Zhao, Zhishu Li, Xin Li, Lixia Dong · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
25. EML4−ALK Variant-Specific Genetic Interactions Shape Lung Tumorigenesis
    Alberto Diaz-Jimenez, Emily G. Shuldiner, Kálmán Somogyi, Karen Y. Shih, Óscar González-Velasco, Mulham Najajreh, Stewart J. Kim, Filiz Akkas, Christopher W. Murray, Laura Andrejka et al. · 2025 · Cancer Discovery
26. A compendium of next-generation patient-derived models for diverse cancers
    Dina ElHarouni, Mushriq Al‐Jazrawe, Seongmin Choi, Merve Dede, Toshinori Hinoue, Sean A. Misek, Heeju Noh, Luca Zanella, Yuen-Yi Tseng, Hayley E. Francies et al. · 2026 · Nature
27. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K / AKT signaling pathway
    Mingchun Li, Zhihua Liu, Zan Hou, Xiangcai Wang, Huaqiu Shi, Yamei Li, Xuewen Xiao, Zhixian Tang, Jianqiong Yang, Yaoling Luo et al. · 2023 · Thoracic Cancer
28. Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes
    Sahil Seth, Runzhe Chen, Yang Liu, Junya Fujimoto, Lingzhi Hong, Alexandre Reuben, Susan Varghese, Carmen Behrens, Tina L. McDowell, Luisa M. Solis Soto et al. · 2024 · Cancer Innovation
29. Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles
    Prabhat Singh Malik, Neha Pathak, Aparna Sharma, Meghna Birla, Abhay Rastogi, Abha Sharma, Sachin Khurana, Deepam Pushpam, Ishaan Gupta, Amber Rathore et al. · 2025 · Clinical Lung Cancer
30. Anti-Angiogenic Therapy in ALK Rearranged Non-Small Cell Lung Cancer (NSCLC)
    Aaron C. Tan, Nick Pavlakis · 2022 · International Journal of Molecular Sciences
31. Chromoplexy: A Pathway to Genomic Complexity and Cancer Development
    Franck Pellestor, Benjamin Ganne, Jean Baptiste Gaillard, Vincent Gâtinois · 2025 · International Journal of Molecular Sciences
32. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells
    Yong Li, Huiqin Huang, Zhenghui Huang, Nanding Yu, Xiang-Li Ye, Mei-Chen Jiang, Limin Chen · 2023 · Diagnostic Pathology
33. Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report
    Janna-Lisa Velthaus, Peter Iglauer, Ronald Simon, Carsten Bokemeyer, Peter Bannas, Niklas Beumer, Charles David Imbusch, Eray Goekkurt, Sonja Loges · 2021 · Oncology Research and Treatment
34. Whole genome duplication in oral squamous cell carcinoma in patients younger than 50 years: implications for prognosis and adverse clinicopathological factors
    Laveniya Satgunaseelan, Dario Strbenac, Cali E. Willet, Tracy Chew, Rosemarie Sadsad, James Wykes, Tsu-Hui Hubert Low, Wendy A. Cooper, C. Soon Lee, Carsten Erich Palme et al. · 2022 · Genes Chromosomes and Cancer
35. Multiplexed In Vivo Screening Using Barcoded Aptamer Technology to Identify Oligonucleotide-Based Targeting Reagents
    Brian J. Thomas, Caitlyn Guldenpfennig, Mark A. Daniëls, Donald H. Burke, David Porciani · 2024 · Nucleic Acid Therapeutics
36. EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells
    Akihiko Miyanaga, Masaru Matsumoto, Jessica A. Beck, Izumi Horikawa, Takahiro Oike, Hirokazu Okayama, Hiromi Tanaka, Sandra Sczerba Burkett, Ana I. Robles, Khan Ma et al. · 2021 · BMC Cancer
37. Mako: A Graph-Based Pattern Growth Approach to Detect Complex Structural Variants
    Jiadong Lin, Xiaofei Yang, Walter A. Kosters, Tun Xu, Yanyan Jia, Songbo Wang, Qihui Zhu, Mallory Ryan, Li Guo, Mark Gerstein et al. · 2021 · Genomics Proteomics & Bioinformatics
38. Ultrafast prediction of somatic structural variations by filtering out reads matched to pan-genome k-mer sets
    Jang-il Sohn, Min-Hak Choi, Dohun Yi, A Vipin Menon, Yeon Jeong Kim, Junehawk Lee, Jung Woo Park, Sungkyu Kyung, Seung‐Ho Shin, Byunggook Na et al. · 2022 · Nature Biomedical Engineering
39. Testing the suitability of neuroanatomical tracing method in human fetuses with long years of postmortem delay
    Nail Can Öztürk, Turan Koç · 2022 · Surgical and Radiologic Anatomy
40. Examining the role of extrachromosomal DNA in lung cancer
    Azhar Khandekar, Phuc H. Hoang, Jens Luebeck, Marcos Díaz‐Gay, Wei Zhao, John P. McElderry, Caleb Hartman, Mona Miraftab, Olivia W. Lee, Kara Marie Barnao et al. · 2026 · JNCI Journal of the National Cancer Institute
41. Developmental Insights into Lung Cancer
    Tushar Desai · 2021 · Annual Review of Cancer Biology
42. Anoikis-related genes combined with single cell sequencing: Insights into model specification of lung adenocarcinoma and applicability for prognosis and therapy
    Yiyi Zhou, Zhenli Hu · 2023 · Frontiers in Cell and Developmental Biology
43. TCRP1 activated by mutant p53 promotes NSCLC proliferation via inhibiting FOXO3a
    Hao Liu, Xiaoting Jia, Kai Luo, Xiangzhou Chen, Zhijie Zhang, Danyang Chen, Yixue Gu, Zhimin He, Guopei Zheng · 2022 · Oncogenesis
44. Passenger mutations link cellular origin and transcriptional identity in human lung adenocarcinomas
    Sukanya Panja, Padmaja Mantri, Kofi Ennu Johnson, Juan S. Andrade-Martínez, Soo‐Ryum Yang, Aditya S. Deshpande, Huasong Tian, Shaham Beg, Kentaro Ohara, Alessandro Leal et al. · 2025 · Nature Genetics
45. Optical genome mapping as a high-resolution tool for uncovering cytogenetic complex and cryptic alterations in a cohort of patients with MDS and AML
    Neus Torres Hernández, Elvira Mora, Cristian García-Ruiz, Alvaro Diaz-González, Gayane Avetisyan, David Martı́nez, Alejandro Berenguer-Rubio, Carmen Botella, Carmen Benet, Irene Gómez-Catalán et al. · 2026 · npj Precision Oncology
46. Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
    Qin Zhang, Lujie Yang, Xiao He, Zhaoqian Dang, Xunjie Kuang, Yanli Xiong, Jianwu Zhu, Zhou Huang, Mengxia Li · 2023 · Frontiers in Oncology
47. Early Diagnostic Markers for Esophageal Squamous Cell Carcinoma: Copy Number Alteration Gene Identification and cfDNA Detection
    Jiamin Chen, Xi Liu, Zhihua Zhang, Ruibing Su, Yiqun Geng, Yi Guo, Yimin Zhang, Min Su · 2024 · Laboratory Investigation
48. Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis
    Jyoti Sankar Prusty, Awanish Kumar, Awanish Kumar · 2024 · Critical Reviews in Microbiology
49. Detection of Pretreatment Circulating Tumor DNA Predicts Recurrence after High-Dose Proton Beam Therapy for Early-Stage Non-Small Cell Lung Cancer
    Masaki Nakamura, Shun‐Ichiro Kageyama, Hidenari Hirata, Taku Tochinai, Hidehiro Hojo, Atsushi Motegi, Akinori Kanai, Yutaka Suzuki, Katsuya Tsuchihara, Tetsuo Akimoto · 2023 · International Journal of Radiation Oncology*Biology*Physics
50. Targeted therapies for RET-fusion cancer: Dilemmas and breakthrough
    Sijie Ding, Rong Wang, Shunli Peng, Xiaoqing Luo, Longhui Zhong, Hong Yang, Yueyun Ma, Shiyu Chen, Wei Wang · 2020 · Biomedicine & Pharmacotherapy
51. Hypoxia-inducible APCDD1L-AS1 promotes osimertinib resistance by stabilising DLST to drive tricarboxylic acid cycle in lung adenocarcinoma
    Quanli Zhang, Yi Shen, Yuru Che, Lili Jia, Xiang Xiao, Hao Xu, Chi Su, Kemin Sun, Limin Zheng, Jiawen Xu et al. · 2025 · Journal of Experimental & Clinical Cancer Research
52. Mitotic microhomology-mediated break-induced replication promotes chromoanasynthesis
    Hien-Ping Ngo, Kez Cleal, Sara Seifan, Vanda Miklós, Szymon A. Barwacz, Brian L. Ruis, Siamak A. Kamranvar, Julia W. Grimstead, Ying Liu, Eric A. Hendrickson et al. · 2026 · Nature Communications
53. Notch2 Signaling Drives Cardiac Hypertrophy by Suppressing Purine Nucleotide Metabolism
    Yuhong Wang, Yizhe Li, Shihong Chen, Tingting Yu, Weiyan Sun, Jiao Liu, Huiwen Ren, Yao Zhou, Lu Wang, Xixi Tao et al. · 2025 · Research
54. Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of the Rapamycin Pathway-Related Protein Expression in Lung Squamous Cell Carcinoma and Its Correlation with Lymph Node Metastasis
    Fang Shi, Ling Li · 2022 · Journal of Oncology
55. Prognostic and immunological values of SKA3 for overall survival in lung adenocarcinoma and its RNA binding protein involved mechanisms
    Yinfeng Gu, Jinjin Li, Hongjun Guan, Changpeng Sun · 2023 · Journal of Chemotherapy
56. Genetic alterations affect immune contexture of non-small cell lung cancer: Ukrainian study
    Denys Kozakov, Nazarii M. Kobyliak, Sofiia Livshun, Oleksii Seleznov, Olena Koshyk, Alina Matvieieva, Yaroslav V. Shparyk, Oleksii Kolesnik, Yuliia Moskalenko, О. І. Vynnychenko et al. · 2025 · Frontiers in Medicine
57. Comparative long-term prognosis of early surgery and surgery after surveillance for patients with ground-glass nodule adenocarcinomas
    Feiyang Zhong, Jinhuan Xu, Lijun Wu, Shaohong Zhao · 2024 · Scientific Reports
58. Heterogeneity in lung cancers by single‐cell DNA sequencing
    Li Zhang, Lingxi Chen, Shuai Cheng Li, Mengyao Wang, Chaohui Li, Tingting Song, Yinyun Ni, Ying Yang, Zhiqiang Liu, Menglin Yao et al. · 2023 · Clinical and Translational Medicine
59. Stereotactic ablative radiotherapy for early-stage central lung tumors: status, challenges, and future considerations
    Ming Li, Cheng Zhan · 2019 · Annals of Translational Medicine
60. Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier
    Hanyu Rao, Aiting Wang, Yue Xu, Wenxin Feng, Chunxiao Ma, Ziyi Wang, Wei Zhang, Wenqiong Su, Xiuying XIAO, Wei‐Qiang Gao et al. · 2026 · Advanced Science
61. Integrative Multiomic Classification Reveals Distinct Origins and Evolutionary Trajectories of Thymic Epithelial Tumors
    Seongyeol Park, Kijong Yi, J.L. Lee, Myung Jin Yang, Joo-Hye Song, Joonoh Lim, Taewoo Kim, Seokhwi Kim, Su Min (Alana) Kim, H. S. Kim et al. · 2026 · Cancer Research
62. Clonal evolution and mutational trajectories of metastatic colorectal cancer shaped by anticancer therapies
    Won Hee Lee, Bun Kim, Chang Hyun Nam, Hyun Yang Yeo, Dong Woon Lee, Seong-Jin Park, Jae Hwan Oh, Sung‐Sik Han, Myong Cheol Lim, Hail Kim et al. · 2026 · Nature Communications
63. PD‐1+CXCR5‐CD4+ T cells are correlated with the severity of lung adenocarcinoma malignant processes
    Jin Wang, Yawei Tang, Chunli Wu, Weiping Li, Bing Wang, Minli Jin, Chunlai Yin, Xia Li · 2021 · Scandinavian Journal of Immunology
64. Comprehensive Analysis of Gene Signatures of m6ARNA Methylation Regulators in Lung Adenocarcinoma and Development of a Risk Scoring System
    Chundi Gao, Huayao Li, Wenzhe Ma, Qiming Zhang, Cun Liu, Lijuan Liu, Jing Zhuang, Changgang Sun · 2022 · Journal of Immunology Research
65. Pindel-TD: A Tandem Duplication Detector Based on A Pattern Growth Approach
    Xiaofei Yang, Gaoyang Zheng, Peng Jia, Songbo Wang, Kai Ye · 2024 · Genomics Proteomics & Bioinformatics
66. Clinical relevance and druggability of sole reciprocal kinase fusions: A large‐scale study
    Jiao Feng, Tonghui Ma, Chunyang Wang, Baoming Wang, Qian Liu, Zhengchuang Liu, Hou‐Quan Tao, Zai‐yuan Ye · 2024 · Cancer Medicine
67. Multiple genome pattern analysis and signature gene identification for the Caucasian lung adenocarcinoma patients with different tobacco exposure patterns
    Yanmei Dong, Li-da Qin, Yi-fan Tong, Qi‐En He, Ling Wang, Kai Song · 2020 · PeerJ
68. Partial Response to Crizotinib in a Lung Adenocarcinoma Patient with a Novel FBXO11 (Intergenic)-ALK (Exon 20-29) Fusion
    Jing He, Youyuan Yao, Fei Quan, Zhongyu Lu, Jian Wang, Wen Gao · 2023 · OncoTargets and Therapy
69. Bridging the gap between tumor evolution and clonality diagnostics in multiple lung carcinomas
    Jurriaan Janssen, Michael Allgäuer, Bauke Ylstra, Swip Draijer, Yongsoo Kim, Jan Budczies, Daniel N. Kazdal, Albrecht Stenzinger, Martina Kirchner, Teodora R Radonic · 2026 · Seminars in Cancer Biology
70. Metastasis-related genomic aberrations and evolutionary trajectory in uveal melanoma
    Chang Hyun Nam, Yong Joon Kim, Jeonghwan Youk, Hyo Song Park, Young Seok Ju, Christopher Seungkyu Lee · 2026 · Experimental & Molecular Medicine
71. Tumor-Agnostic Circulating Tumor DNA Analysis as a Comprehensive Predictive Biomarker of Recurrence after Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
    Masaki Nakamura, Shun‐Ichiro Kageyama, Hidenari Hirata, Masaki Ohira, Shunsuke A. Sakai, Yumi Hakozaki, Hidehiro Hojo, Takeshi Fujisawa, Riu Yamashita, Hiroshi Haeno et al. · 2025 · Clinical Lung Cancer
72. Toward Identifying Key Gene Group in the Occurrence and Development of Lung Adenocarcinoma
    Ming Gu, Tian-Fang Zhao, Wei Liu, Xiao-Kun Wu, Liang Yang · 2021 · IEEE Access
73. The ALK receptor tyrosine kinase journey: From physiological roles to pathological disruptions
    Fabrizio Tabbò, Luisella Righi, Riccardo Taulli, Silvia Novello · 2021 · Elsevier eBooks
74. Role of Radiation-related Lung Function Genes in Prognosis and Immune Infiltration of Lung Adenocarcinoma
    Fei Teng, Xiaojing Sun, Yuge Ran, Чан Лю, Hongyun Shi, Yuan Tian · 2024 · Combinatorial Chemistry & High Throughput Screening
75. Comparing the effectiveness of attachment-based play therapy and parent-child relationship therapy on the psychological well-being of children with separation anxiety disorder
    Mahsa Najmi, Reza Ghorban Jahromi, Esmail Saadipour, Mansoureh Karimzadeh · 2024 · Journal of Psychological Science
76. Analysis of Cell and Nucleus Genome by Next-Generation Sequencing
    Ji Won Oh, Alexej S. Abyzov · 2020 · Springer eBooks
77. ID2 inhibits lung adenocarcinoma cell malignant behaviors by inhibiting the activation of the PI3K/AKT/mTOR signaling pathway
    Wenzhong Peng, Jia Chen, Ruoxi He, Yongjun Tang, Juan Jiang, Ying Li · 2022 · Tissue and Cell
78. Somatic Mutation But Not Aneuploidy Differentiates Lung Cancer in Never-Smokers and Smokers
    Sitapriya Moorthi, Amy L. Paguirigan, Minjeong Ko, Mary B. Pettinger, Anna C. H. Hoge, Anwesha Nag, Neil A. Patel, Feinan Wu, Cassie L. Sather, Matthew Fitzgibbon et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
79. Identification of Novel Lung Adenocarcinoma Subtypes and Prognostic Gene Sets Based on GSVA Analysis
    Jianxu Yuan, Jiawu Wang, Qing Jiang, Zhengzhao Hua, Sheng‐Jie Yu · 2023 · Research Square
80. Landscape of Large-Scale Somatic Genomic Insertions in Non-Small Cell Lung Carcinoma Revealed by Nanopore Sequencing
    Dan Xie, Xia Lin, Zhoufeng Wang, Tianfu Zeng, Xuenan Pi, Huan Wang, Guonian Zhu, Xinyue Wu, Yangqian Li, Yan Deng et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
81. APOBEC3A drives deaminase mutagenesis in human gastric epithelium
    Yohan An, Ji‐Hyun Lee, Joonoh Lim, Jeonghwan Youk, Seongyeol Park, Ji‐Hyung Park, Kijong Yi, Taewoo Kim, Chang Hyun Nam, Won Hee Lee et al. · 2025 · Genome Research
82. Panorama of Chromosomal Instability in Lung Cancer
    Yang Yang, Xiaoming Zhong, William Phillips, Zhao Wei, Phuc H. Hoang, Christopher Wirth, Soo‐Ryum Yang, Charles Leduc, Marina K. Baine, William David Travis et al. · 2025 · medRxiv
83. SETD2 deficiency impairs β-catenin destruction complex to facilitate renal cell carcinoma formation
    Hanyu Rao, Xiaoxue Li, Min Liu, Jing Liu, Wenxin Feng, Jin Xu, Wei‐Qiang Gao, Li Li · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
84. A Dream of Red Mansions: Researching the Art of Generalist Art Teaching.
    Anne Bamford · 1999
85. Characteristic of Classification and Prognostic Scoring Based on M6a RNA Methylation Modification in Lung Adenocarcinoma and Tumor Microenvironment Association
    Xiaoming Yu, Mingming Han, Zhucheng Zhao, Yanfan Chen, Liangxing Wang · 2022 · Research Square
86. Faculty Opinions recommendation of Mechanisms generating cancer genome complexity from a single cell division error.
    Dana Branzei, Barnabás Szakál · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
87. Deciphering the Evolutionary History of Complex Rearrangements in Head and Neck Cancer Patients Using Multi-Omic Approach
    Jeesoo Chae, Jin Seok Lee, Jongkeun Park, Dong-Sung Lee, Weon Seo Park, Benjamin Clock, Jesse R. Dixon, Yuh‐Seog Jung, Dongwan Hong · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
88. Comprehensive analysis of the prognostic role and mutational characteristics of m6A-related genes in lung adenocacinoma
    Jinghua Chen, Xiangpeng Chu, Zihao Chen, Bi-Jun Chen, Shao-Kun Jiang, Rafael Rosell, Wen‐Zhao Zhong · 2022 · Research Square
89. Patterns of somatic mutations in normal cells
    Freek Manders · 2023
90. Data from Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells
    Anna Saurina Solé, Sandrine Grossetête, Maxime Heintzé, Loélia Babin, Sakina Zaïdi, Patrick Revy, Benjamin Renouf, Anne De Cian, Carine Giovannangeli, Cécile Pierre‐Eugène et al. · 2023
91. Data from Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions
    Harshabad Singh, Yvonne Y. Li, Liam Flinn Spurr, Atul Bhanudas Shinagare, Ritika Abhyankar, Emma Reilly, Lauren K. Brais, Anwesha Nag, Matthew D. Ducar, Aaron R. Thorner et al. · 2023
92. Loss of Setd2 Induces the Upregulation of Genes Related to Akt/Mtor Signaling Pathway
    Zhouyang Zhou, Yuan Xu · 2023 · BIO Web of Conferences
93. Additional file 2 of Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification
    Chen Gao, Ning Kong, Fan Zhang, Tianyu Tang, Jiaying Li, Honglei Ding, Zhichao Sun, Linyu Wu, Maosheng Xu · 2022 · Figshare
94. Additional reporting of diffuse and homogeneous ROS-1 SP384 immunoreactivity enhances prediction of ROS1 fusion–positive non-small cell lung cancer
    Bokyung Ahn, Se Jin Jang, Hee Sang Hwang · 2024 · American Journal of Clinical Pathology
95. Chromoplexy
    Franck Pellestor, Jean Baptiste Gaillard, Benjamin Ganne, Vincent Gâtinois · 2025 · Methods in molecular biology
96. Additional file 1 of Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers
    Peiyi Xia, Zhang, Lan, Li, Pan, Liu, Enjie, Li, Wencai, Zhang, Jianying, Hui Li, Xiaoxing Su, Jiang Guozhong · 2021 · Figshare
97. Additional file 1 of METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma
    Wu, Yingtong, Chang, Ning, Zhang, Yong, Zhang, Xinxin, Leidi Xu, Yinggang Che, Qiao, Tianyun, Wu, Bin, Zhou, Ying, Jiang, Jun et al. · 2021 · Figshare
98. Additional file 1 of EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells
    Miyanaga, Akihiko, Matsumoto, Masaru, Beck, Jessica A., Izumi Horikawa, Oike, Takahiro, Okayama, Hirokazu, Hiromi Tanaka, Burkett, Sandra S., Robles, Ana I., Khan, Mohammed et al. · 2021 · Figshare
99. Additional file 2 of METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma
    Wu, Yingtong, Chang, Ning, Zhang, Yong, Zhang, Xinxin, Leidi Xu, Yinggang Che, Qiao, Tianyun, Wu, Bin, Zhou, Ying, Jiang, Jun et al. · 2021 · Figshare
100. Additional file 1 of Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification
     Gao, Chen, Ning Kong, Zhang, Fan, Tang, Tianyu, Li, Jiaying, Honglei Ding, Sun, Zhichao, Wu, Linyu, Xu, Maosheng · 2022 · Figshare